CNC vs HUM
Centene Corporation and Humana, both Healthcare
Humana is the larger company at $43B against $30B. Over the past year CNC returned +103% against +65% for HUM. The RyuScore puts HUM ahead, 73 against 27 out of 100.
| Figure | CNC | HUM |
|---|---|---|
| Last close | $65.37 | $431 |
| Market cap | $30B | $43B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 46.0 |
| Dividend yield | n/a | 0.8% |
| 1-year return | +103% | +65% |
| 5-year return | +3.9% | +11% |
| RyuScoresector-relative, 1–10 | 27/100 | 73/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 52% of the disclosed total.
Humana
Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 89% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.